Marc Tessier-Lavigne, Xaira Therapeutics CEO

Ex­clu­sive: Marc Tessier-Lav­i­gne on leav­ing Stan­ford and join­ing biotech’s new AI mega-start­up

Ear­li­er Tues­day, End­points News re­port­ed that for­mer Stan­ford pres­i­dent Marc Tessier-Lav­i­gne will lead one of biotech’s biggest-ever start­up launch­es: Xaira Ther­a­peu­tics, which has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.